Victrix Investment Advisors bought a new stake in Cardinal Health, Inc. (NYSE:CAH - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 2,559 shares of the company's stock, valued at approximately $303,000.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. Norges Bank acquired a new stake in Cardinal Health in the 4th quarter valued at about $246,748,000. Marshall Wace LLP boosted its stake in Cardinal Health by 154.6% in the fourth quarter. Marshall Wace LLP now owns 3,151,736 shares of the company's stock valued at $372,756,000 after acquiring an additional 1,913,892 shares during the last quarter. Castlekeep Investment Advisors LLC bought a new stake in shares of Cardinal Health during the 4th quarter valued at $141,963,000. Junto Capital Management LP acquired a new position in shares of Cardinal Health in the 4th quarter valued at $92,811,000. Finally, 8 Knots Management LLC acquired a new position in shares of Cardinal Health in the 4th quarter valued at $62,476,000. 87.17% of the stock is currently owned by institutional investors and hedge funds.
Analyst Ratings Changes
A number of equities research analysts recently commented on the company. Citigroup reiterated a "neutral" rating on shares of Cardinal Health in a report on Thursday, May 1st. Bank of America upped their price target on Cardinal Health from $150.00 to $155.00 and gave the company a "buy" rating in a research note on Friday, April 11th. Wells Fargo & Company increased their price target on shares of Cardinal Health from $135.00 to $136.00 and gave the company an "equal weight" rating in a research report on Tuesday, February 4th. Argus set a $148.00 price objective on shares of Cardinal Health in a report on Tuesday, February 4th. Finally, Robert W. Baird upped their price objective on shares of Cardinal Health from $156.00 to $170.00 and gave the company an "outperform" rating in a research report on Friday, May 2nd. Four research analysts have rated the stock with a hold rating, ten have issued a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus target price of $146.43.
Read Our Latest Research Report on CAH
Cardinal Health Stock Down 0.6%
Shares of NYSE:CAH traded down $0.90 during midday trading on Thursday, reaching $152.41. The company had a trading volume of 1,129,337 shares, compared to its average volume of 2,228,555. Cardinal Health, Inc. has a 1-year low of $93.17 and a 1-year high of $156.44. The stock has a market cap of $36.38 billion, a PE ratio of 28.43, a P/E/G ratio of 1.49 and a beta of 0.66. The business's 50 day moving average price is $138.70 and its 200 day moving average price is $128.54.
Cardinal Health (NYSE:CAH - Get Free Report) last announced its quarterly earnings results on Thursday, May 1st. The company reported $2.35 EPS for the quarter, beating analysts' consensus estimates of $2.15 by $0.20. The firm had revenue of $54.88 billion during the quarter, compared to analysts' expectations of $55.33 billion. Cardinal Health had a net margin of 0.59% and a negative return on equity of 59.57%. The company's revenue for the quarter was up .0% compared to the same quarter last year. During the same quarter last year, the company posted $2.08 earnings per share. On average, research analysts expect that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.
Cardinal Health Increases Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, July 15th. Stockholders of record on Tuesday, July 1st will be given a $0.5107 dividend. This represents a $2.04 dividend on an annualized basis and a dividend yield of 1.34%. This is a boost from Cardinal Health's previous quarterly dividend of $0.51. The ex-dividend date of this dividend is Tuesday, July 1st. Cardinal Health's dividend payout ratio (DPR) is presently 31.83%.
About Cardinal Health
(
Free Report)
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
Featured Articles

Before you consider Cardinal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardinal Health wasn't on the list.
While Cardinal Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.